[1] 陈玉莲,李运明,秦杨,等.晚期非小细胞肺癌患者凝血功能异常的相关因素与预后的分析[J].中国医学前沿杂志,2017,9(3):41-45. [2] CAO J, FU Z, GAO L, et al.Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma[J]. World J Surg Oncol, 2017, 15(1):48. [3] KOMURCUOGLU B, ULUSOY S, GAYAF M, et al.Prognostic value of plasma D-dimer levels in lung carcinoma[J]. Tumori, 2011, 97(6): 743-748. [4] FUKUMOTO K, TANIGUCHI T, USAMI N, et al.The preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer[J]. Surg Today, 2015, 45(1): 63-67. [5] 臧玉芹,刘祗平,步玉晴,等.D-二聚体、纤维蛋白原、血小板水平评估老年晚期非小细胞肺癌放疗的效果[J].中国老年学杂志,2015,35(22):6583-6584. [6] 陈喜军,窦敏,林一.肿瘤患者血浆抗凝血酶Ⅲ、FDP和D-二聚体的结果分析[J].实验与检验医学,2014,32(1):46-47. [7] 毛德奎,秦海峰,于爱平,等.肺癌患者化疗前后凝血、纤溶功能与血小板参数的变化及其临床意义[J].军事医学,2012,36(2):141-146. [8] ANTONIOU D, PAVLAKOU G, STATHOPOULOS G P, et al.Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer[J]. Lung Cancer, 2006, 53(2):205-210. [9] WOLNY-ROKICKA E, BRZEŹNIAKIEWICZ-JANUS K, Wydmański J, et al. Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment[J]. J Int Med Res, 2018, 46(5): 1876-1883. [10] 赵成礼,张高高,潘雪峰,等.肺癌放射治疗前后血清D-二聚体水平变化与无病生存时间关系的研究[J].山西医药杂志,2015,44(13):1459-1461. |